Publication:
Antimicrobial peptide modifications against clinically isolated antibiotic-resistant salmonella

dc.contributor.authorSuthee Mangmeeen_US
dc.contributor.authorOnrapak Reamtongen_US
dc.contributor.authorThareerat Kalambahetien_US
dc.contributor.authorSittiruk Roytrakulen_US
dc.contributor.authorPiengchan Sonthayanonen_US
dc.contributor.otherFaculty of Tropical Medicine, Mahidol Universityen_US
dc.contributor.otherThailand National Center for Genetic Engineering and Biotechnologyen_US
dc.date.accessioned2022-08-04T08:06:53Z
dc.date.available2022-08-04T08:06:53Z
dc.date.issued2021-08-01en_US
dc.description.abstractAntimicrobial peptides are promising molecules to address the global antibiotic resistance problem, however, optimization to achieve favorable potency and safety is required. Here, a pep-tide-template modification approach was employed to design physicochemical variants based on net charge, hydrophobicity, enantiomer, and terminal group. All variants of the scorpion venom peptide BmKn-2 with amphipathic α-helical cationic structure exhibited an increased antibacterial potency when evaluated against multidrug-resistant Salmonella isolates at a MIC range of 4–8 µM. They revealed antibiofilm activity in a dose-dependent manner. Sheep red blood cells were used to evaluate hemolytic and cell selectivity properties. Peptide Kn2-5R-NH2, dKn2-5R-NH2, and 2F-Kn2-5R-NH2 (variants with +6 charges carrying amidated C-terminus) showed stronger antibacterial activity than Kn2-5R (a variant with +5 charges bearing free-carboxyl group at C-terminus). Peptide dKn2-5R-NH2 (D-enantiomer) exhibited slightly weaker antibacterial activity with much less hemolytic activity (higher hemolytic concentration 50) than Kn2-5R-NH2 (L-enantiomer). Furthermore, peptide Kn2-5R with the least hydrophobicity had the lowest hemolytic activity and showed the highest specificity to Salmonella (the highest selectivity index). This study also explained the relationship of peptide physicochemical properties and bioactivities that would fulfill and accelerate progress in peptide antibiotic research and development.en_US
dc.identifier.citationMolecules. Vol.26, No.15 (2021)en_US
dc.identifier.doi10.3390/molecules26154654en_US
dc.identifier.issn14203049en_US
dc.identifier.other2-s2.0-85112672549en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/76081
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85112672549&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleAntimicrobial peptide modifications against clinically isolated antibiotic-resistant salmonellaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85112672549&origin=inwarden_US

Files

Collections